The long term goal of this project is to delineate the molecular mechanisms whereby the uneven distribution of zinc, the synthesis of zinc metallothionein, and the zinc-mediated events associated with synaptic events in various areas of brain are regulated. The immediate objective of this proposal is to assess the role of zinc metallothionein in preventing the generation of oxygen radicals and oxidative damage in the brain. Since many zinc containing neurons are also glutamatergic neurons, and since the mammalian hippocampus is enriched with zinc, glutamate and NMDA receptors, these studies will be carried out in hippocampal neurons in primary culture. It is hypothesized that during the inflammatory responses, the cytokine-induced induction of metallothionein provides a long lasting protection to minimize damage by oxidative stress, such as free radicals.
The specific aims of this proposal are: 1) to assess the consequence of depleting the level of glutathione by buthionine-SR- sulfoximine, of depleting the level of metallothionein by oligodeoxynucleotide, and of inducing the synthesis of metallothionein by interleukin-1 on the cytotoxicity of an organic hydroperoxide in hippocampal neurons; 2) to learn whether the induction of metallothionein by interleukin-1 can prevent the apoptotic cell death brought about by inhibition of superoxide dismutase; and 3) to ascertain whether or not the induction of and the hydroxyl radical scavenging properties of metallothionein are associated with altered activity of nitric oxide synthase. The concentrations of zinc are reduced in the brains of patients with Parkinson's disease and amyotrophic lateral sclerosis; and oxidative damage has been implicated in both conditions. The results to be gained from these studies will provide an additional insight on the role of zinc metallothionein in oxidative stress associated with these and other neurological disorders.

Agency
National Institute of Health (NIH)
Institute
National Institute of Neurological Disorders and Stroke (NINDS)
Type
Research Project (R01)
Project #
5R01NS034566-03
Application #
2460627
Study Section
Neurology A Study Section (NEUA)
Program Officer
Streicher, Eugene
Project Start
1995-08-01
Project End
1998-07-31
Budget Start
1997-08-01
Budget End
1998-07-31
Support Year
3
Fiscal Year
1997
Total Cost
Indirect Cost
Name
University of Nebraska Medical Center
Department
Pharmacology
Type
Schools of Medicine
DUNS #
City
Omaha
State
NE
Country
United States
Zip Code
68198
Ajjimaporn, Amornpan; Shavali, Shaik; Ebadi, Manuchair et al. (2008) Zinc rescues dopaminergic SK-N-SH cell lines from methamphetamine-induced toxicity. Brain Res Bull 77:361-6
Sharma, Sushil; Ebadi, Manuchair (2008) SPECT neuroimaging in translational research of CNS disorders. Neurochem Int 52:352-62
Wanpen, Sawitri; Kooncumchoo, Patcharee; Shavali, Shaik et al. (2007) Salsolinol, an endogenous neurotoxin, activates JNK and NF-kappaB signaling pathways in human neuroblastoma cells. Neurochem Res 32:443-50
Kooncumchoo, Patcharee; Sharma, Sushil; Porter, James et al. (2006) Coenzyme Q(10) provides neuroprotection in iron-induced apoptosis in dopaminergic neurons. J Mol Neurosci 28:125-41
Ebadi, Manuchair; Brown-Borg, Holly; Ren, Jun et al. (2006) Therapeutic efficacy of selegiline in neurodegenerative disorders and neurological diseases. Curr Drug Targets 7:1513-29
Dhanasekaran, Muralikrishnan; Uthayathas, Subramaniam; Karuppagounder, Senthilkumar S et al. (2006) Ebselen effects on MPTP-induced neurotoxicity. Brain Res 1118:251-4
Shavali, Shaik; Combs, Colin K; Ebadi, Manuchair (2006) Reactive macrophages increase oxidative stress and alpha-synuclein nitration during death of dopaminergic neuronal cells in co-culture: relevance to Parkinson's disease. Neurochem Res 31:85-94
Ajjimaporn, Amornpan; Swinscoe, John; Shavali, Shaik et al. (2005) Metallothionein provides zinc-mediated protective effects against methamphetamine toxicity in SK-N-SH cells. Brain Res Bull 67:466-75
Bollimuntha, Sunitha; Singh, Brij B; Shavali, Shaik et al. (2005) TRPC1-mediated inhibition of 1-methyl-4-phenylpyridinium ion neurotoxicity in human SH-SY5Y neuroblastoma cells. J Biol Chem 280:2132-40
Chagkutip, Jaturaporn; Govitrapong, Piyarat; Klongpanichpak, Sirirat et al. (2005) Mechanism of 1-methyl-4-phenylpyridinium-induced dopamine release from PC12 cells. Neurochem Res 30:633-9

Showing the most recent 10 out of 39 publications